ArticleCell death & disease2025

MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway.

Pei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.